Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: coherus-biosciences.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
10 filings
$560K on those filings
Intelligence
INT
7 filings
$270K on those filings
Defense
DEF
7 filings
$270K on those filings
Government Issues
GOV
5 filings
$250K on those filings
Medical/Disease Research/Clinical Labs
MED
5 filings
$30K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
H.R. 5054114th CongressAgriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 20173 filingsthrough 2016
H.R. 5376117th CongressAn act to provide for reconciliation pursuant to title II of S. Con. Res. 14.2 filingsthrough 2022
H.R. 8319116th CongressContinuing Appropriations Act, 2021 and Other Extensions Act2 filingsthrough 2020
H.R. 8406116th CongressMaking emergency supplemental appropriations for the fiscal year ending September 30, 2021, and for other purposes.2 filingsthrough 2020
S. 771115th CongressImproving Access To Affordable Prescription Drugs Act2 filingsthrough 2017
S. 3311118th CongressAmerican Made Pharmaceuticals Act of 20231 filingthrough 2023
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
John StromFoley & Lardner LLPCovered position: Senior Counsel - U.S. House Cmte on Energy & Commerce; Counsel - U.S. Senate Cmte on Health, Education, Labor, and Pensions; Associate General Counsel - U.S. Dept of Health and Human Services; Senior Counsel - U.S. House Cmte on Natural Resources
6 filingsthrough 2026
Josh NarrowThe Conafay Group, LLCCovered position: Intern for Senator Casey6 filingsthrough 2024
Darin L GardnerThe Conafay Group, LLCCovered position: Legislative Correspondent Senator Tim Hutchinson; Research Associate Senate HELP Committee; Chief of Staff Congresswoman Kay Granger6 filingsthrough 2024
Kristen LafayetteThe Conafay Group, LLC6 filingsthrough 2024
Bryan ShuyThe Conafay Group, LLCCovered position: Chief of Staff Rep. Harris; Asst. to Rep. Harris, House Cmte on Approps; Dep. Asst. Sec and Chief of Staff HHS/Asst. Secretary for Preparedness and Response (ASPR)5 filingsthrough 2024
Covered positions · 4 of 10 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
